| Identification | Back Directory | [Name]
SULAMSEROD | [CAS]
219757-90-1 | [Synonyms]
RS-100302
SULAMSEROD
Methanesulfonamide, N-[2-[4-[3-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-oxopropyl]-1-piperidinyl]ethyl]- | [Molecular Formula]
C19H28ClN3O5S | [MDL Number]
MFCD09837836 | [MOL File]
219757-90-1.mol | [Molecular Weight]
445.96 |
| Chemical Properties | Back Directory | [Boiling point ]
647.8±65.0 °C(Predicted) | [density ]
1.319±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
11.22±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
Sulamserod is a 5-HT4 receptor antagonist, with antiarrhythmic activities. | [in vivo]
Sulamserod (30 mg/kg) prolongs mean ERP (11568 versus 14667 ms, P,0.01) and wavelength (8.360.9 versus 9.960.8 cm, P,0.01), reduces dispersion of ERP (1565 versus 861 ms, P,0.01), and minimally slows conduction velocity (7264 versus 6765 cm/s, P,0.01) in pigs. Sulamserod produces no ventricular electrophysiological effects. Sulamserod terminates atrial flutter in 6 of 8 animals and atrial fibrillation in 8 of 9 animals and prevents reinduction of sustained tachycardia in all animals[1]. | [IC 50]
5-HT4 Receptor | [References]
[1] Rahme MM, et al. Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT(4) receptor antagonist RS-100302 in experimental atrial flutter and fibrillation. Circulation. 1999 Nov 9;100(19):2010-7. DOI:10.1161/01.cir.100.19.2010 |
|
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|